These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7693968)

  • 1. Mutated primer binding sites interacting with different tRNAs allow efficient murine leukemia virus replication.
    Lund AH; Duch M; Lovmand J; Jørgensen P; Pedersen FS
    J Virol; 1993 Dec; 67(12):7125-30. PubMed ID: 7693968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alleviation of murine leukemia virus repression in embryonic carcinoma cells by genetically engineered primer binding sites and artificial tRNA primers.
    Modin C; Lund AH; Schmitz A; Duch M; Pedersen FS
    Virology; 2000 Dec; 278(2):368-79. PubMed ID: 11118360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of functional tRNA primers and primer binding site sequences from a retroviral combinatorial library: identification of new functional tRNA primers in murine leukemia virus replication.
    Lund AH; Duch M; Pedersen FS
    Nucleic Acids Res; 2000 Feb; 28(3):791-9. PubMed ID: 10637332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preferred region for recombinational patch repair in the 5' untranslated region of primer binding site-impaired murine leukemia virus vectors.
    Mikkelsen JG; Lund AH; Kristensen KD; Duch M; Sørensen MS; Jørgensen P; Pedersen FS
    J Virol; 1996 Mar; 70(3):1439-47. PubMed ID: 8627661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine leukemia virus with a primer-binding site complementary to tRNALys,3 adapts to select new tRNAs for replication following extended in vitro culture.
    Palmer MT; McPherson S; Morrow CD
    Virology; 2005 Mar; 333(2):337-48. PubMed ID: 15721366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementation of a primer binding site-impaired murine leukemia virus-derived retroviral vector by a genetically engineered tRNA-like primer.
    Lund AH; Duch M; Lovmand J; Jørgensen P; Pedersen FS
    J Virol; 1997 Feb; 71(2):1191-5. PubMed ID: 8995641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replication of avian leukosis viruses with mutations at the primer binding site: use of alternative tRNAs as primers.
    Whitcomb JM; Ortiz-Conde BA; Hughes SH
    J Virol; 1995 Oct; 69(10):6228-38. PubMed ID: 7545245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of alterations of primer-binding site sequences on human immunodeficiency virus type 1 replication.
    Li X; Mak J; Arts EJ; Gu Z; Kleiman L; Wainberg MA; Parniak MA
    J Virol; 1994 Oct; 68(10):6198-206. PubMed ID: 7521916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replication and pathogenicity of primer binding site mutants of SL3-3 murine leukemia viruses.
    Lund AH; Schmidt J; Luz A; Sørensen AB; Duch M; Pedersen FS
    J Virol; 1999 Jul; 73(7):6117-22. PubMed ID: 10364369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in both the U5 region and the primer-binding site influence the selection of the tRNA used for the initiation of HIV-1 reverse transcription.
    Kang SM; Wakefield JK; Morrow CD
    Virology; 1996 Aug; 222(2):401-14. PubMed ID: 8806524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening by tRNA primer extension analysis of porcine kidney mRNA libraries defines a novel endogenous porcine retroviral long terminal repeat.
    Hoopes CW; Platt JL
    Transplantation; 1999 Jun; 67(11):1391-5. PubMed ID: 10385075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of murine leukemia virus replication complemented by yeast tRNA(Phe) reveals inherent preferences for the tRNA primer selected for reverse transcription.
    Palmer MT; Morrow CD
    Virology; 2004 Jul; 324(2):430-8. PubMed ID: 15207628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced replication of human immunodeficiency virus type 1 mutants that use reverse transcription primers other than the natural tRNA(3Lys).
    Das AT; Klaver B; Berkhout B
    J Virol; 1995 May; 69(5):3090-7. PubMed ID: 7707537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The zinc finger of nucleocapsid protein of Friend murine leukemia virus is critical for proviral DNA synthesis in vivo.
    Yu Q; Darlix JL
    J Virol; 1996 Sep; 70(9):5791-8. PubMed ID: 8709195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target-cell-derived tRNA-like primers for reverse transcription support retroviral infection at low efficiency.
    Schmitz A; Lund AH; Hansen AC; Duch M; Pedersen FS
    Virology; 2002 May; 297(1):68-77. PubMed ID: 12083837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. tRNA isoacceptor preference prior to retrovirus Gag-Pol junction links primer selection and viral translation.
    Palmer MT; Kirkman R; Kosloff BR; Eipers PG; Morrow CD
    J Virol; 2007 May; 81(9):4397-404. PubMed ID: 17301132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic evidence of the interaction between tRNA(Lys,3) and U5 facilitating efficient initiation of reverse transcription by human immunodeficiency virus type 1.
    Zhang Z; Kang SM; Morrow CD
    AIDS Res Hum Retroviruses; 1998 Jul; 14(11):979-88. PubMed ID: 9686644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus type 1 can use different tRNAs as primers for reverse transcription but selectively maintains a primer binding site complementary to tRNA(3Lys).
    Wakefield JK; Wolf AG; Morrow CD
    J Virol; 1995 Oct; 69(10):6021-9. PubMed ID: 7545240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a type 1 human immunodeficiency virus that maintains a primer binding site complementary to tRNA(His).
    Wakefield JK; Kang SM; Morrow CD
    J Virol; 1996 Feb; 70(2):966-75. PubMed ID: 8551637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal sequence requirements of a functional human immunodeficiency virus type 1 primer binding site.
    Wakefield JK; Rhim H; Morrow CD
    J Virol; 1994 Mar; 68(3):1605-14. PubMed ID: 7508999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.